In contrast, four of the five Eμ-Myc/cRel−/− lymphomas showed no significant reduction in lymphoid tumour burden after CCT244747 treatment, with one lymphoma only exhibiting a partial response in the thymus and cervical lymph nodes. This evidence concerns the gene MYC and lymphoid neoplasm.